pharmacology (non-hormonal) Flashcards
which % of pregnancies is affected by:
i. HTN
ii. PET
i. 10%
ii. 3%
clear indications for rx of raised BP in pregnancy (4):
persistant BP >160/110
acute severe HTN
fulminating PET
eclampsia
BP above which we medicate
150/100
beta blockers SE:
IUGR
neonatal hypoglycaemia and bradycardia (rare)
which BB is sometimes CI as their effect in early and late pregnancy is not known?
atenolol
methyldopa
(2nd line)
mechanism of action:
centrally acting
is metabolised to α-methylnoradrenaline (it’s active component)
It works as a post-synaptic α2 agonist reducing central sympathetic outflow
methyldopa SE
- rebound HTN
- depressed mood with LT use
- Flattened CTG variability
- Autoimmune haemolytic anaemia (rare)
- Raised prolactin (outside of pregnancy)
- Hepatitis
nifedipine
(not licensed in pregnancy but commonly used 2nd line)
- use MR as acutely can cause hypotension
effects of nifedipine:
- member of the dihydropyridine group and
blocks inward flux of calcium through voltage
gated calcium channels - has a preferential effect on vessels as a vasodilator rather than the myocardium
- known effect on the myometrium – it
may inhibit premature labour (unlicensed use) and
has been used as a tocolytic agent
nifedipine SE:
- Acute hypotension if given sub-lingually
- Peripheral oedema
- Headache + flushing
hydralazine
(iv used for acute HTN)
how is it metabolised and by which organ?
by acetyaltion in liver
hydralazine SE:
- acute hypotension if given too fast or often (give over 5 mins at least, up to every 15 mins max)
- lupus-like syndrome (v rarely - in pts who acetlyate slowly)
magnesium sulphate:
(has rapid onset of action- maintained for 24 hrs post delivery/ fit)
i. how does it work?
ii. in which instances would you require monitoring?
i. membrane stabiliser
ii. if oliguric
magnesium sulphate SE:
- hyporeflexia (presents in advance of more serious SE)
- resp depression
- cardio-respiratory arrest
antihypertensives to avoid in pregnancy:
- ACEi
- thiazide diuretics
ACEi associations:
- Congenital malformations – especially CVS
- Skull defects
- Oligohydramnios + impaired fetal renal function
effect on neonate with bendroflumethiazde:
neonatal thrombocytopaenia
indications for tocolysis:
- To achieve 24 hour steroid latency < 34 weeks
- to allow for in-utero transfer
drugs used for tocoloysis:
- nifedipine
- atosiban
less commonly:
- beta-sympathomimetics (salbutamol, ritodrine,
terbutaline) NICE recommends avoid - magnesium sulphate - recommended for neuroprotection from 24–30 weeks gestation and possibly 30–34 weeks
- GTN patches - no better than ritodrine but less SE
beta-sympathomimetics (salbutamol, ritodrine,
terbutaline)
SE
tachycardia
hypotension
pulmonary oedema
hypokalaemia
hyperglycaemia
i. which medication is given prior to ECV (external cephalic version) to improve success rates?
ii. in only which group of women is this done?
iii. SE of this medication
i. terbutaline s/c
ii. primagravida
iii. transient maternal tachycardia and tremor